APR 13, 2017 10:30 AM PDT

Why Variants Matter: NGS Bioinformatics Simplified for Oncology & Virology

SPONSORED BY: Vela Diagnostics
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Vice President of Precision Oncology, Vela Dx
    Biography
      Condie Carmack, Ph.D. received his Ph.D. from the University of Utah in Experimental Pathology and did postdocs in Philadelphia, PA and San Diego, CA. in mouse genetics and molecular biology. He is the author or or co-author of 23 peer-reviewed journal. He wrote the first paper on quantitative PCR and the second paper on multiplex PCR. He served on the Science Advisory Board of Life Technologies Inc. as an expert in clinical PCR. He was co-author on the first paper creating human monoclonal antibodies from immunodeficient mice. Mice serve as the foundation for creation of the current immune checkpoint blockade antibodies such as ipilimumab and nivolumab. He also served as General Manager of the Cancer Genetics Lab at Baylor College of Medicine before joining Vela Diagnostics
    • Director of Scientific Support for Vela Diagnostics, Bioinformatics Applications scientist
      Biography
        Ahmed Mahmoud is an experienced scientist with both hands-on lab and bioinformatics experience with degrees in both molecular biology and bioinformatics. Ahmed is currently the Director of Scientific Support for Vela Diagnostics as well as a Bioinformatics Applications scientist. Ahmed's team handles all technical wet lab and informatics support for Vela Diagnostic's qPCR and NGS workflows, assisting with pipeline creation for various NGS workflows and robotic application writing for automated systems. He has experience developing qPCR and Automated NGS workflows as well as extensive experience in NGS data analysis using multiple sequencing platforms. He has held positions in various areas of the biotech industry with institutions such as GeneDX, Pfizer and Columbia University Medical Center. Ahmed is also an avid iOS developer, creating computer apps geared towards the science sector.

      Abstract:

      Next-generation sequencing is expected to take molecular diagnostics to the next level with the capability to perform deep analysis of genetic information that leads to targeted therapies perfectly matched to the situation. However, adoption of this technology in the clinic has been slower than expected due to various factors including ease-of-use, expense, footprint, and data complexity.  Today many of these hurdles have been overcome as NGS workflows have become increasingly automated, smaller, and less expensive.  For many in the clinic, the key to making this technology more accessible is automated bioinformatics that supports clinical decision-making.

      In this presentation we will delve into the sequencing world from the perspective of the variant.  We’ll uncover how today’s sophisticated bioinformatics engines can take raw sequencing data and transform the results into accurate and actionable reports that point to therapies and clinical trials.  We will explore this concept for clinical oncology and clinical virology and show how software today automates the process from sample-to -answer.


      Show Resources
      You May Also Like
      MAY 24, 2018 09:30 AM PDT
      C.E. CREDITS
      MAY 24, 2018 09:30 AM PDT
      DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
      AUG 15, 2018 08:00 AM PDT
      C.E. CREDITS
      AUG 15, 2018 08:00 AM PDT
      DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
      JUN 26, 2018 06:00 AM PDT
      C.E. CREDITS
      JUN 26, 2018 06:00 AM PDT
      Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
      JUN 20, 2018 10:00 AM EDT
      C.E. CREDITS
      JUN 20, 2018 10:00 AM EDT
      DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
      AUG 16, 2018 08:00 AM PDT
      C.E. CREDITS
      AUG 16, 2018 08:00 AM PDT
      DATE: August, 16, 2018TIME: 08:00AM PDTThis webinar will review recent advancements in the application of next-generation sequencing of T cell receptor beta (TCRB) chain repertoires towards...
      MAY 03, 2018 11:00 AM PDT
      MAY 03, 2018 11:00 AM PDT
      DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
      Loading Comments...